Trial De Novo reqires each award to be equal to or greater than $5000

The $5,000 Threshold for Trial De Novo Review

New York’s no-fault insurance system includes a mandatory arbitration component for disputes between insurers and healthcare providers. However, arbitration is not the final word—Insurance Law § 5106(b) provides for judicial review of arbitration awards through either limited review under CPLR Article 75 or full trial de novo depending on the award amount. The statutory threshold distinguishing these review levels has significant implications for litigation strategy and case outcomes.

The Appellate Term, First Department’s decision in Imperium Insurance Co. v. Innovative Chiropractic Services, P.C. addresses the application of the $5,000 threshold for trial de novo review. The court’s holding that each individual arbitration award must meet the $5,000 threshold—rather than evaluating consolidated awards in the aggregate—creates important planning considerations for both insurers and providers in the no-fault system.

This threshold requirement also highlights divergent jurisdictional grants between the New York City Civil Court Act and the Uniform District Court Act. As Jason Tenenbaum’s analysis observes, these statutory differences create practical consequences for parties choosing forums and structuring their claims, potentially incentivizing strategic claim-splitting to avoid de novo review.

Case Background

In Imperium Insurance Co. v. Innovative Chiropractic Services, P.C., the plaintiff insurer commenced multiple declaratory judgment actions seeking review of master arbitrator’s awards issued in favor of defendant medical providers. The insurer consolidated five separately issued awards, none of which individually exceeded $5,000, and sought plenary trial de novo review of all awards under Insurance Law § 5106(b).

The Civil Court initially exercised jurisdiction over the consolidated actions pursuant to NYCCCA § 212-a, which grants Civil Court authority over declaratory judgment actions. However, on appeal, the parties disputed whether the court had authority to conduct trial de novo review when individual awards fell below the $5,000 statutory threshold, even though the consolidated awards exceeded that amount in the aggregate.

The Appellate Term considered whether the $5,000 threshold in Insurance Law § 5106(b) should be applied to each individual award or whether consolidated awards could be aggregated to meet the threshold. The court also addressed whether Civil Court possessed subject matter jurisdiction to entertain the declaratory judgment action even if plenary review was unavailable.

Jason Tenenbaum’s Analysis:

Imperium Ins. Co. v Innovative Chiropractic Servs., P.C, 2014 NY Slip Op 50697(U)(App. Term 1st Dept. 2014)

The plaintiff insurer commenced the underlying actions, consolidated below, seeking declaratory relief and review by way of trial de novo of five separately issued master arbitrator’s awards issued in favor of defendant medical providers on their claims for first-party no-fault benefits. While Civil Court had jurisdiction to entertain the lawsuit (see CCA 212-a; Brooks v Rivera, 40 Misc 3d 133, 2013 NY Slip Op 51191 ), we sustain the dismissal of the consolidated actions on the merits. De novo review of a master arbitrator’s award is limited to the grounds set forth in CPLR article 75 unless the award is in the amount of $5,000 or more, in which case the dispute is subject to a “plenary judicial adjudication” pursuant to Insurance Law § 5106(b) (see Matter of Greenberg , 70 NY2d 573, 576-577 )

Compare this to: Liberty Mut. Ins. Co. v Bayside Pain & Rehabilitation Medicine, P.C., 39 Misc.3d 148(A)(App. Term 2d Dept. 2013)(construing DISTRICT COURT act). I am curious why the Legislature gave a broader grant of jurisdiction in the NYCCCA as opposed to the UDCA. As to the $5,000 rule, my only remark is that the Appellate Term has now incentivized the splitting of no-fault billings to avoid eventual de-novo review.

Legal Significance

The Appellate Term’s holding that each individual arbitration award must meet the $5,000 threshold for trial de novo review establishes an important limitation on insurers’ ability to secure plenary judicial review. By refusing to aggregate multiple awards for purposes of the statutory threshold, the court prevents insurers from consolidating small-dollar awards to manufacture jurisdiction for trial de novo. This interpretation protects the arbitration system from excessive judicial interference in low-value disputes.

However, the decision creates a critical distinction between subject matter jurisdiction and scope of review. The Appellate Term confirmed that Civil Court possesses subject matter jurisdiction over declaratory judgment actions seeking review of arbitration awards pursuant to NYCCCA § 212-a, even when the awards fall below the $5,000 threshold. This jurisdictional grant is independent of the question whether plenary review or limited CPLR Article 75 review applies.

The practical consequence of this framework is that insurers can bring declaratory judgment actions challenging sub-$5,000 awards, but their review is limited to the narrow grounds specified in CPLR Article 75: whether the award was procured by corruption, fraud, or misconduct; whether arbitrators exceeded their powers; or whether arbitrators failed to make a final determination of issues submitted. Substantive challenges to the arbitrators’ factual findings or legal conclusions are generally foreclosed under CPLR Article 75’s deferential standard.

Jason Tenenbaum’s comparison to the Second Department’s decision in Liberty Mutual Insurance Co. v. Bayside Pain & Rehabilitation Medicine, P.C. highlights an important statutory divergence. The Uniform District Court Act, which governs courts outside New York City, apparently provides a broader jurisdictional grant than the New York City Civil Court Act for these types of actions. This disparity creates potential forum-shopping opportunities depending on where parties are located and where actions may be commenced.

More provocatively, Jason Tenenbaum observes that the $5,000 threshold incentivizes providers to split their no-fault billings across multiple claims to ensure individual awards remain below the threshold. This strategic behavior would insulate awards from plenary review, making them effectively unreviewable except on the narrow CPLR Article 75 grounds. While such claim-splitting may raise questions about manipulation of the arbitration system, the Appellate Term’s decision appears to permit this approach.

Practical Implications

For insurance carriers challenging arbitration awards, Imperium Insurance requires careful evaluation of whether individual awards meet the $5,000 threshold before filing declaratory judgment actions seeking plenary review. When awards fall below the threshold, insurers should assess whether grounds exist for limited review under CPLR Article 75. If no such grounds exist—meaning the arbitrators acted within their authority and without fraud or misconduct—judicial review will likely prove futile regardless of whether the substantive award was erroneous.

Insurers should also consider whether to challenge multiple sub-$5,000 awards in a single consolidated action or through separate actions. While consolidation may promote judicial efficiency, it does not overcome the individual threshold requirement. Insurers might achieve better results by focusing resources on awards that individually exceed $5,000 and accepting others as final, rather than pursuing unproductive litigation over low-value awards.

For medical providers, the decision confirms that arbitration awards below $5,000 receive significant insulation from judicial review. Providers should consider this protection when structuring claims and determining whether to pursue arbitration of multiple small claims separately or consolidate them. While billing practices should be driven primarily by medical necessity and coding accuracy, the litigation implications of claim structure merit consideration.

The potential for claim-splitting identified by Jason Tenenbaum raises ethical and practical questions. Providers who artificially divide billings solely to avoid de novo review risk running afoul of insurance fraud statutes or no-fault regulations prohibiting billing manipulation. However, legitimate billing practices that happen to result in multiple sub-$5,000 awards appear permissible under the current statutory framework.

From a systemic perspective, the $5,000 threshold may need legislative reconsideration. When the threshold was established, $5,000 represented a more substantial amount in terms of purchasing power. Inflation has eroded the threshold’s value, potentially resulting in fewer awards qualifying for plenary review than the Legislature originally intended. Adjusting the threshold for inflation or establishing a lower threshold for consolidated awards might better serve the statute’s purposes.

Related Articles

• Supplemental affirmation requirements and res judicata in declaratory judgment cases
• Second Department guidance on declaratory judgment actions
• First Department’s approach to declaratory judgment victories
• Procedural missteps and notice requirements in DJ cases
• Denial of Claims practice area

Legal Update (February 2026): Since this 2014 post, the monetary threshold for trial de novo review under Insurance Law § 5106(b) may have been adjusted, and related procedural requirements for declaratory judgment actions involving master arbitrator awards may have been modified through regulatory amendments or legislative updates. Practitioners should verify current threshold amounts and jurisdictional provisions before proceeding with such actions.

Related: What “de novo” means in New York — trial de novo and de novo review, explained.